About the REACH Awards
What is it?
The REACH Awards program is designed to advance high quality research in heart and kidney disease and stems from a joint effort between Bayer, Women in Nephrology (WIN), and the National Kidney Foundation (NKF). The REACH Awards are intended to support a community of healthcare professionals (HCPs), fellows, clinical researchers, scientists, and epidemiologists currently working within the field of heart and kidney diseases. Applications for the REACH Awards will be evaluated on innovation, quality of the research proposal/approach, and anticipated impact to the cardiorenal field.
Research focus
Applicants may propose any clinical or population research in the cardiovascular and kidney areas for the 2024/2025 cycle of the Reach Awards. For example,
- Sex/gender differences in heart and kidney health
- Gaps and barriers in care for heart and kidney diseases
- Underserved/underrepresented populations with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)
- Guideline-directed medical therapies for CKD-T2D and/or heart failure
- The role of aldosterone in disease biology
- CKD in a cardiovascular disease setting
- Implementation science
- Patient-reported outcomes in CKD and T2D
Applicants will be required to describe how their proposed research will translate into clinical benefits for patients with cardiovascular and renal conditions. The applications that offer the most compelling translational opportunities will be given greater weight during the review process.
About the Grants Review Committee
Select experts from Bayer, WIN, and NKF will constitute the Grants Review Committee.
Reviewers from WIN and NKF will be compensated for their application review efforts.
How to apply for a REACH Award
- Interested parties are invited to complete a letter of intent (LOI) proposal. The purpose of the LOI proposal is to allow for screening of the grant concept; the LOI proposal does not in any manner bind the investigator, Bayer, WIN, and NKF in a contractual agreement.
- The deadline for LOI proposal submission is December 13, 2024.
- All LOI proposals will be reviewed by the Grants Review Committee, which is comprised of independent experts from WIN and NKF, as well as Bayer experts from the renal and cardiovascular fields.
- Following review by the committee, successful applicants will be notified and invited to submit a research protocol, inclusive of a final itemized budget.
- Research protocols will be reviewed by the committee and chosen applicants will be notified as final award recipients. Chosen research protocols will undergo a Bayer fair market value assessment.
Dates and deadlines
REACH Awards timeline – 2024/2025 cycle
- Deadline for submission of LOI proposals: December 13, 2024
- Applicants informed of decision: January 31, 2025
- Deadline for submission of research protocols: March 15, 2025
- Applicants notified of decision: April 15, 2025
